Abstract
AbstractThe COVID-19 pandemic across Chinese mainland was gradually stabilized at a low level with sporadic outbreaks, before the emergence of Omicron variant. Apart from non-pharmacological interventions (NPIs), COVID-19 vaccine has also been implemented to prevent and control the pandemic since early 2021. Although many aspects have been focused, the change of the spatiotemporal distribution of COVID-19 epidemic across Chinese mainland responding to the change of prevention and control measures were less concerned. Here, we collected the confirmed case data (including domestic cases and overseas imported cases) across Chinese mainland during both 2020/04–2020/08 and 2021/04–2021/08, and then conducted a preliminary data comparison on the spatiotemporal distribution of confirmed cases during the identical period between the two years. Distribution patterns were evaluated both qualitatively by classification method and quantitatively through employing coefficient of variation. Results revealed significant differences in the homogeneity of spatiotemporal distributions of imported or domestic cases between the two years, indicating that the important effect of the adjustment of prevention and control measures on the epidemic evolution. The findings here enriched our practical experience of COVID-19 prevention and control. And, the collected data here might be helpful for improving or verifying spatiotemporally dynamic models of infectious diseases.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382(13), 1199–1207 (2020).
2. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19pandemic. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
3. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed 7 Jun 2023 (2022).
4. Lu, J. et al. Sensitivity to COVID-19 vaccine effectiveness and safety in Shanghai, China. Vaccines 9(5), 472 (2021).
5. Ioannidis, J. P. The end of the COVID-19 pandemic. Eur. J. Clin. Invest. 52(6), e13782 (2022).